No, Shockingly Altaba Isn't the Dumbest Corporate Name Ever Created
Here's What to Expect for UnitedHealthcare's Fourth-Quarter Earnings

Here's What to Expect for UnitedHealthcare's Fourth-Quarter Earnings

Here's Why Johnson & Johnson Shares Are Poised for a Rally

Here's Why Johnson & Johnson Shares Are Poised for a Rally

Mylan Crushed by Trump, Cigna and CVS -- All In Two Days

Mylan Crushed by Trump, Cigna and CVS -- All In Two Days

Patent Victory Secures Lilly Hold on Cancer Drug Until 2022

Patent Victory Secures Lilly Hold on Cancer Drug Until 2022

CVS Is the Latest to Rock Mylan's EpiPen Empire

CVS Is the Latest to Rock Mylan's EpiPen Empire

Cigna Will No Longer Cover Mylan's EpiPen

Cigna Will No Longer Cover Mylan's EpiPen

Cigna Defends Abandoning EpiPen Coverage

Cigna Defends Abandoning EpiPen Coverage

Bristol-Myers and AstraZeneca Take Beatings

Bristol-Myers and AstraZeneca Take Beatings